These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1082 related articles for article (PubMed ID: 32997601)

  • 1. Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.
    Robbins PD; Jurk D; Khosla S; Kirkland JL; LeBrasseur NK; Miller JD; Passos JF; Pignolo RJ; Tchkonia T; Niedernhofer LJ
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():779-803. PubMed ID: 32997601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
    Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
    FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular senescence: a key therapeutic target in aging and diseases.
    Zhang L; Pitcher LE; Yousefzadeh MJ; Niedernhofer LJ; Robbins PD; Zhu Y
    J Clin Invest; 2022 Aug; 132(15):. PubMed ID: 35912854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
    Lagoumtzi SM; Chondrogianni N
    Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into targeting cellular senescence with senolytic therapy: The journey from preclinical trials to clinical practice.
    Chen P; Wang Y; Zhou B
    Mech Ageing Dev; 2024 Apr; 218():111918. PubMed ID: 38401690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Cellular Senescence with Senotherapeutics: Development of New Approaches for Skin Care.
    Thompson EL; Pitcher LE; Niedernhofer LJ; Robbins PD
    Plast Reconstr Surg; 2022 Oct; 150():12S-19S. PubMed ID: 36170431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Potential Role and Therapeutic Relevance of Cellular Senescence in Skeletal Pathophysiology.
    Li B; Lyu P; Tang J; Li J; Ouchi T; Fan Y; Zhao Z; Li L
    J Gerontol A Biol Sci Med Sci; 2024 Apr; 79(4):. PubMed ID: 38306619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senescence and the SASP: many therapeutic avenues.
    Birch J; Gil J
    Genes Dev; 2020 Dec; 34(23-24):1565-1576. PubMed ID: 33262144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing Strategies.
    Calabrò A; Accardi G; Aiello A; Caruso C; Galimberti D; Candore G
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
    Khalil R; Diab-Assaf M; Lemaitre JM
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular senescence in bone.
    Farr JN; Khosla S
    Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The costs and benefits of senotherapeutics for human health.
    Raffaele M; Vinciguerra M
    Lancet Healthy Longev; 2022 Jan; 3(1):e67-e77. PubMed ID: 36098323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin aging-cellular senescence : What is the future?].
    Scharffetter-Kochanek K; Wang Y; Makrantonaki E; Crisan D; Wlaschek M; Geiger H; Maity P
    Dermatologie (Heidelb); 2023 Sep; 74(9):645-656. PubMed ID: 37638987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National Institute on Aging Workshop: Repurposing Drugs or Dietary Supplements for Their Senolytic or Senomorphic Effects: Considerations for Clinical Trials.
    Romashkan S; Chang H; Hadley EC
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1144-1152. PubMed ID: 33528569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Senolytic and senomorphic interventions to defy senescence-associated mitochondrial dysfunction.
    Nehlin JO
    Adv Protein Chem Struct Biol; 2023; 136():217-247. PubMed ID: 37437979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets.
    Rossi M; Abdelmohsen K
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria-targeted senotherapeutic interventions.
    Atayik MC; Çakatay U
    Biogerontology; 2022 Aug; 23(4):401-423. PubMed ID: 35781579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsp90 inhibitors as senolytic drugs to extend healthy aging.
    Fuhrmann-Stroissnigg H; Niedernhofer LJ; Robbins PD
    Cell Cycle; 2018; 17(9):1048-1055. PubMed ID: 29886783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the fuzzy border between senolytics and senomorphics with chemoinformatics and systems pharmacology.
    Olascoaga-Del Angel KS; Gutierrez H; Königsberg M; Pérez-Villanueva J; López-Diazguerrero NE
    Biogerontology; 2022 Aug; 23(4):453-471. PubMed ID: 35781578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Senotherapeutics for mesenchymal stem cell senescence and rejuvenation.
    Wong PF; Dharmani M; Ramasamy TS
    Drug Discov Today; 2023 Jan; 28(1):103424. PubMed ID: 36332835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.